发明名称 CD28 PATHWAY IMMUNOREGULATION.
摘要 Use of an anti-CD28 antibody or a F(ab')2 fragment thereof in the manufacture of a medicament for administration to a population of CD3-activated CD28<+> T-cells of a patient to promote the production of a cyclosporine resistant lymphokine selected from IL-2, TNF, IFN-gamma and GM-CSF.
申请公布号 EP0637963(A4) 申请公布日期 1996.07.10
申请号 EP19930910570 申请日期 1993.04.06
申请人 THE REGENTS OF THE UNIVERSITY OF MICHIGAN;THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY 发明人 THOMPSON, CRAIG, B.;JUNE, CARL, H.
分类号 C12N15/02;A61K35/14;A61K35/28;A61K38/00;A61K38/17;A61K38/46;A61K39/395;A61P31/18;A61P37/04;C07K14/705;C07K16/00;C07K16/28;C12N5/0783;C12N5/10;C12P21/02;C12P21/08 主分类号 C12N15/02
代理机构 代理人
主权项
地址